| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |